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Background and aims: Periodontitis, a common polymicrobial inflammatory disease in the tooth sup-
porting tissues, is a risk factor for coronary artery disease. One of the proposed underlying mechanisms is
the systemic immune response to periodontal infection. We studied how serum antibodies against seven
periodontal pathogens and their subgingival levels associate with each other, periodontitis, and coronary
artery disease.
Methods: The Parogene cohort included 505 Finnish patients (mean age 63 y) who underwent coronary
angiography, and clinical and radiographic oral examinations. Coronary diagnosis was defined as no
significant coronary artery disease (<50% stenosis, n ¼ 152), stable coronary artery disease (50% ste-
nosis, n ¼ 184) and acute coronary syndrome (n ¼ 169). Levels of subgingival Aggregatibacter actino-
mycetemcomitans, Porphyromonas gingivalis, Porphyromonas endodontalis, Prevotella intermedia,
Tannerella forsythia, Campylobacter rectus, and Fusobacterium nucleatum were determined by checker-
board DNA-DNA hybridization. Serum antibody (IgA/IgG) levels were analyzed with enzyme-linked
immunosorbent assay (ELISA). Aggregate IgA/IgG burdens were calculated by summing and standard-
izing the serum antibody levels.
Results: Patients with active periodontitis were characterized by higher levels of subgingival bacteria and
corresponding IgA/IgG response. Quartiles 2e4 of serum IgA/IgG burden indicated higher risk for acute
coronary syndrome (OR 1.84, 95%CI 1.01e3.35 for IgA; OR 1.87, 95%CI 1.01e3.46 for IgG) independently of
established cardiovascular risk factors, body mass index, number of teeth, subgingival bacterial levels
and periodontal diagnosis.
Conclusions: Our findings support the hypothesis that the association between periodontitis and car-
diovascular diseases is partly mediated by the immunologic response for periodontal pathogens.
© 2017 Elsevier B.V. All rights reserved.1. Introduction
Periodontitis is a chronic inflammatory disease in the tooth
supporting tissues. It is one of the most common diseases world-
wide; the severe form has a global age-standardized prevalence of
11.2% [1]. Periodontitis is preceded by gingivitis, and progresses as aeases, University of Helsinki,
, FI-00014, Helsinki, Finland.
ljestrand).complex interplay between putative periodontal pathogens and
host response in susceptible individuals. If left untreated, the
resulting resorption of alveolar bone leads to increased tooth
mobility and eventually loss of teeth [2]. The deleterious effects of
periodontitis are, however, not restricted to the oral cavity. Peri-
odontitis may cause bacteremia, endotoxemia, and systemic low
grade inflammation [3].
Even though periodontitis has been regarded as a polymicrobial
infection for a century, the exact influence of periodontal patho-
gens is still under research. Some species, such as Aggregatibacter
actinomycetemcomitans, Porphyromonas gingivalis, Prevotella
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bacterium nucleatum form complexes that associatewith each other
in a virulent manner, and are traditionally considered as peri-
odontal pathogens [4]. The development of sequencing techniques
has enabled identification of new putative periodontal pathogens.
Porphyromonas endodontalis is one of the proposed candidates with
a moderate grade of evidence [5]. The emerging concept of peri-
odontal pathogenesis emphasizes the role of polymicrobial synergy
caused by keystone pathogens and dysbiosis in the subgingival
biofilm community [6].
The confounder independent association between periodontitis
and atherosclerotic vascular disease is widely recognized and
consistent through diverse populations [7,8]. One of the mecha-
nistic explanations is the activation of adaptive immunity towards
invasive periodontal pathogens, resulting in molecular mimicry by
cross-reactive T, or B lymphocytes [9]. Several periodontal patho-
gens incorporate antigens, which share homology with human
epitopes, and the resulting auto-reactive antibodies may induce
endothelial dysfunction, systemic inflammation and promote
atherogenesis [3,10]. These oral pathogens promote atherogenesis
both directly, by virulence factors and endothelial invasion, which
activates pro-atherogenic mechanisms, and via immunologic
mechanisms, such as cross-activation between host- and pathogen
antigens [11]. Therefore, high serum antibody levels to periodontal
pathogens are likely to have both direct effects on the development
of coronary artery disease (CAD) and simultaneously indicate
periodontal infection [12]. From a clinical perspective, systemic
antibody responses to periodontal pathogens have been proposed
as surrogate markers for periodontitis [13e15].
It has been described repeatedly that cardiovascular risk asso-
ciates with the inflammatory burden consisting of multiple mi-
crobial species [16e18]. Periodontitis is a polymicrobial disease, its
pathogens share common surface antigens with the host, and some
of the bacterial species have been associated with atherosclerosis.
The relationships of the aggregate periodontal pathogen burden,
their immune responses and CAD have not been reported before.
We investigated these associations utilizing a well characterized
population having angiographically verified coronary artery dis-
ease diagnosis as well as comprehensive clinical oral examinations
with data on a select group of periodontal pathogens and serum
antibody levels.
2. Materials and methods
2.1. Population
The Corogene cohort consists of 5297 Finnish patients who
underwent coronary angiography between June 2006 and March
2008 at the Helsinki University Central Hospital as previously
described [19]. A random gender-stratified subsample (N ¼ 505)
was enrolled for extensive clinical, and radiographic oral exami-
nations. These individuals constitute the Parogene cohort used in
this study. The study complies with the principles of the Declara-
tion of Helsinki and adheres to the STROBE guidelines for obser-
vational studies. Informed consent was obtained from all study
subjects. The study design was approved by the Helsinki University
Central Hospital ethics committee (approval reference number 106/
2007).
2.2. Examinations
The oral examinations were performed by two calibrated peri-
odontal specialists (PM and KB) who were unaware of the coronary
status. The data collection has been described in detail [20]. Among
other parameters “bleeding on probing” (BOP) was registered as aproxy for active gingival inflammation [21]. Periodontal pocket
probing depth (PPD) wasmeasured from six sites on each tooth and
number pockets with PPD 4e5 mm and PPD 6 mm were regis-
tered [20]. Periodontal inflammatory burden index was calculated
by adding the number of periodontal pockets indicating mild to
moderate periodontitis (PPD 4e5 mm) to the weighted number of
periodontal pockets indicating more advanced periodontitis
(number of periodontal pockets with PPD 6 mm multiplied by
two) as previously reported [20,22]. This index takes into account
the enlargement of inflamed subgingival surface area in deepened
periodontal pockets. Alveolar bone loss (ABL), a hallmark of peri-
odontitis, and the number of teeth present were determined from
panoramic radiographs. Periodontal diagnosis was defined as
“healthy” (no ABL and BOP<25%, n ¼ 46), “gingivitis” (no ABL and
BOP25%, n ¼ 65), “history of periodontitis” (mild-severe ABL and
BOP<25%, n ¼ 92) and “active periodontitis” (mild-severe ABL,
BOP25%, n ¼ 269). These definitions for the periodontal diagnosis
have been reported earlier [23]. Edentulous subjects (n ¼ 33) lack
periodontal diagnosis.
Subgingival bacterial samples were collected from the deepest
periodontal pocket in each quadrant [24]. Bacterial levels of seven
studied periodontal pathogens, A. actinomycetemcomitans, P. gin-
givalis, P. endodontalis, P. intermedia, T. forsythia, C. rectus and
F. nucleatum, were analyzed with checkerboard DNA-DNA hybrid-
ization [25,26]. Bacterial prevalence was defined as level >0.
Information on weight, height and smoking was obtained from
questionnaires. Subjects were considered having hypertension,
dyslipidemia or diabetes mellitus if they had respective mediations.
Coronary diagnosis was acquired from the coronary artery angi-
ography, symptoms, and laboratory determinations as follows: no
significant CAD/controls (<50% stenosis, n ¼ 152), stable CAD
(50% stenosis, n ¼ 184), acute coronary syndrome (ACS; 50%
stenosis, an episode of typical chest pain, and elevated levels of a
cardiac biomarkers, n ¼ 169) [19]. Blood samples were drawn and
stored at 80 C.
Serum levels of immunoglobulin A and G (IgA/IgG) against
whole cell antigen of all studied bacteria were determined with
enzyme-linked immunosorbent assay (ELISA) [27]. When the an-
tigen composed of several strains, the bacterial suspensions with
aligned densities were mixed in equal volumes before coating the
plates. The serum samples were analyzed as duplicates and two
dilutions. The mean absorbance values from four wells were
calculated and normalized per reference serum samples on each
plate and used as a continuous variable [28,29].
A. actinomycetemcomitans and P. endodontalis IgA/IgG de-
terminations have been described earlier [30,31] and the remaining
laboratory analyses were performed for this study. The used bac-
terial strains (DNA-DNA hybridization/ELISA), ELISA dilutions and
inter-assay coefficients of variations are displayed on Supplemental
Table 1. We summed the levels of subgingival
A. actinomycetemcomitans (two strains) and F. nucleatum (four
strains) after controlling that the prevalence of any single strain
does not affect the corresponding serum antibody response (non-
significant in Mann-Whitney U and Students T- tests, data not
shown).
2.3. Statistical analyses
The statistical analyses were performed with the SPSS statistics
software (version 24; IBM Corp, Armonk, NY, USA). Comparison
between groups was performed with the Mann-Whitney U test
(non-normal) for continuous variables and c2 test for categorical
variables. The levels of subgingival bacteria and their correspond-
ing serum antibodies were standardized with Z-score prior to
analysis to increase normality and to facilitate comparison between
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IgA/IgG levels for the studied species were summed and stan-
dardized to acquire parameters that reflect the IgA/IgG burden.
The distributions of serum antibody-levels were visually
inspectedwith population pyramid histograms, split by subgingival
bacterial presence. The number of teeth present, periodontal in-
flammatory burden index, smoking and age were analyzed for
potential interaction effects with factorial ANOVA, as these have
been proposed as effect modifiers [32]. Associations between
continuous variables were determined with a confounder adjusted
linear regression model. Post hoc test with logistic regression
models were performed for statistically significant associations.
3. Results
3.1. Population characteristics
Basic demographics and cardiovascular risk factors across the
studied population (N ¼ 505) are displayed on Table 1. Most of the
population represent older adults, while 71%were over 60 years old
(mean age 63.4, SD 9.1). Stable CAD and ACS were characterized by
a higher proportion of male subjects, diabetes mellitus, hyperten-
sion, and dyslipidemia, compared to subjects without significant
coronary stenosis. Periodontal disease was highly prevalent in the
population; only 9% were periodontally healthy and 53% had active
periodontitis. Edentulous subjects (n¼ 33) are presented alongside
true periodontal diagnoses, as they represent an end-point for oral
diseases.
3.2. Subgingival bacteria and immunological response
We examined the association between subgingival prevalence
of studied bacterial species (A. actinomycetemcomitans, P. gingivalis,
P. endodontalis, P. intermedia, T. forsythia, C. rectus, F. nucleatum) and
serum IgA and IgG levels to these species (Table 2). The serum
antibody levels were generally higher for bacteria-positive subjects.
However, the serum antibody levels had a high deviation and the
differences were statistically significant only for P. gingivalis (IgA
and IgG), P. endodontalis (IgA and IgG) and P. intermedia (IgG). All
species were highly prevalent in the studied population (66e93%).
Population pyramid inspection revealed that a dominance of lowTable 1
Characteristics of subjects according to coronary status.
No CAD, n ¼ 152
Mean (SD)
Age (years) 61.2 (9.2)
hs-CRP 6.6 (13.3)
n (%)
Gender (male) 70 (46.1)
Diabetes mellitus 26 (17.1)
Smoking (ever) 71 (46.7)
Hypertension 86 (56.6)
Dyslipidemia 107 (70.4)
Rheumatoid arthritis 7 (4.6)
Periodontal diagnosis Healthy 18 (11.8)
Gingivitis 28 (18.4)
History of periodontitis 27 (17.8)
Active periodontitis 70 (46.1)
Edentulous 9 (5.9)
Periodontal diagnosis: healthy (no ABL and BOP<25%), gingivitis (no ABL and BOP25%),
severe ABL, BOP25%), periodontal diagnosis not applicable for edentulous subjects. Sta
ACS, acute coronary syndrome; CAD, coronary artery disease; hs-CRP, high-sensitivity C
a Mann-Whitney U test.
b c2 test; "No CAD00 used as the reference.serum antibody levels dilutes tests of significance, even though
subjects with strong immunological response were generally pos-
itive for the corresponding bacteria. After controlling for interaction
effects, we found that the positive association between subgingival
T. forsythia prevalence and serum IgA was significant among never
smokers, whereas F. nucleatum associated with IgG response
among subjects below 65 years of age. The subgingival burden
associated with serum antibody burden in a linear regression
model adjusted for age, gender, smoking (never/ever) and number
of teeth (F[5454] ¼ 9.666, p < 0.001 for IgA and F[5454] ¼ 9.299,
p < 0.001 for IgG).3.3. Periodontal status
The groups of periodontal diagnoses were characterized by
pocket probing depth measurements (number of pockets with PPD
4e5mmor6mm) and periodontal inflammatory burden index as
continuous variables (Supplemental Fig. 1). Both history of peri-
odontitis and active periodontitis were associated with higher
pocket measures compared to periodontally healthy controls
(p < 0.05). We examined the subgingival levels and corresponding
serum IgA/IgG levels for all studied pathogens across diagnoses for
periodontitis and edentulous subjects (Supplemental Table 2).
Subgingival bacterial- and serum IgA/IgG burdens across groups of
periodontal diagnoses are illustrated as error bars in Fig. 1, where
all parameters were compared to periodontally healthy subjects. In
general, periodontitis was associated with higher levels of sub-
gingival bacteria and humoral immune response against them.
Gingivitis associated significantly with higher levels of
P. endodontalis and T. forsythia. History of periodontitis associated
significantly with elevated immune response to P. gingivalis (IgA/
IgG), P. endodontalis (IgA/IgG), P. intermedia (IgA) and combined
serum antibody burden (IgA/IgG). Active periodontitis associated
significantly with elevated levels of A. actinomycetemcomitans (IgA/
IgG), P. gingivalis (subgingival/IgA/IgG), P. endodontalis (subgingival/
IgA/IgG), P. intermedia (subgingival/IgA), T. forsythia (subgingival),
C. rectus (subgingival), and subgingival/IgA/IgG burden. The find-
ings were similar when adjusting for age, gender, and smoking in a
multinomial logistic regression model (data not shown). In sum-
mary, both a history of periodontitis, and active periodontitis were
characterized by higher immunological responses to seven studiedStable CAD, n ¼ 184 ACS, n ¼ 169
p-valuea Mean (SD) p-valuea
65.5 (8.2) < 0.001 62.9 (9.6) 0.077
4.1 (7.9) 0.002 19.3 (35.5) < 0.001
p-valueb n (%) p-valueb
136 (73.9) < 0.001 122 (72.2) < 0.001
55 (29.9) 0.005 37 (21.9) 0.294
99 (53.8) 0.178 97 (57.4) 0.056
129 (70.1) 0.008 107 (63.3) 0.219
172 (93.5) < 0.001 125 (74.0) 0.535
11 (6.0) 0.570 11 (6.5) 0.459
14 (7.6) 0.044 14 (8.3) 0.175
16 (8.7) 21 (12.4)
42 (22.8) 23 (13.6)
100 (54.3) 99 (58.6)
12 (6.5) 12 (7.1)
history of periodontitis (mild-severe ABL and BOP<25%), active periodontitis (mild-
tistically significant results (p < 0.05) are bolded.
-reactive protein.
Table 2
Subgingival bacterial prevalence and corresponding serum antibodies.
IgA Subgingival prevalence p-valuea
e þ n (%) prevalent
Median (IQR)
A. actinomycetemcomitans 0.14 (0.98) 0.34 (1.05) 407 (86) 0.282
P. gingivalis 0.65 (0.73) 0.39 (1.44) 380 (80) 0.014
P. endodontalis 0.53 (0.89) 0.31 (1.19) 312 (66) 0.032
P. intermedia 0.24 (1.08) 0.24 (0.98) 332 (70) 0.543
T. forsythia 0.27 (0.91) 0.23 (0.89) 361 (76) 0.925
C. rectus 0.22 (1.26) 0.20 (1.15) 396 (83) 0.612
F. nucleatum 0.35 (0.85) 0.29 (0.89) 442 (93) 0.918
IgG
A. actinomycetemcomitans 0.26 (1.15) 0.27 (1.19) 407 (86) 0.883
P. gingivalis 0.70 (1.15) 0.17 (1.78) 380 (80) < 0.001
P. endodontalis 0.39 (1.19) 0.15 (1.74) 312 (66) 0.040
P. intermedia 0.34 (0.98) 0.19 (0.82) 332 (70) 0.045
T. forsythia 0.25 (1.34) 0.39 (1.06) 361 (76) 0.271
C. rectus 0.14 (1.48) 0.14 (1.25) 396 (83) 0.703
F. nucleatum 0.37 (0.92) 0.25 (1.16) 442 (93) 0.304
Levels of serum antibodies (absorbance units) were standardized with Z-score prior to analyses; Subgingival bacterial data available for n ¼ 476 dentate subjects. Ig,
immunoglobulin. Statistically significant results (p < 0.05) are bolded.
a Mann-Whitney U test.
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neously higher subgingival levels of corresponding bacteria.
3.4. Coronary status
Table 3 shows the levels of studied subgingival bacteria and
their corresponding serum IgA/IgG across groups of coronary di-
agnoses. Compared to subjects without significant coronary ste-
nosis (reference), subjects with stable CAD had more subgingival
A. actinomycetemcomitans and C. rectus -specific IgA. The immu-
nological response was most evident for the group with ACS, who
had significantlymore A. actinomycetemcomitans (IgA/IgG), C. rectus
(IgA), F. nucleatum (IgA) and IgA burden. Even a slight increase in
IgA/IgG burden associated with ACS, and we performed post hoc
analyses accordingly (Table 4). Quartiles 2e4 of IgA/IgG burden
associated significantly with ACS in a logistic regression model
adjusted with age, gender, smoking (never/ever), dyslipidemia,
hypertension, diabetes mellitus, body mass index, and the number
of teeth present (OR 1.98, 95%CI 1.13e3.47, p ¼ 0.017 for IgA; OR
1.84, 95%CI 1.04e3.23, p ¼ 0.035 for IgG). In further analyses, we
added the subgingival burden and the periodontal diagnosis into
the model as covariates. The subgingival burden had no significant
association with ACS and the associations of quartiles 2e4 of IgA/
IgG burdenwith ACS hardly altered suggesting mediation of effects
via immunologic response rather than confounding. No association
was found between quartiles 2e4 of IgA/IgG burden and stable
CAD.
4. Discussion
In this cross-sectional observational study, we found that sub-
jects with a history of periodontitis had elevated levels of serum
antibodies and subjects with active periodontitis had simulta-
neously high subgingival levels of the studied periodontal patho-
gens. Even slightly increased levels of serum IgA/IgG burden
associated with angiographically verified ACS. High levels of IgA
indicate recent or repeated exposure of the antigen and our find-
ings support the hypothesis that an active humoral immune
response to typical periodontal pathogens has important systemic
effects. Analyzing both antigens and antibodies in this well-
characterized population makes this work novel.Atherosclerosis is regarded as a common multifactorial
“response to injury” in the vessel walls. Emerging evidence is
linking bacterial infection to modulation of inflammation, a key
element in all stages of atherogenesis, and initiation of arterial
thrombosis, which causes acute coronary events [33]. A cellular
adaptive immune response plays important modulatory effects on
atherosclerosis, by activation of antigen-presenting cells, B- and T-
lymphocytes [34]. Atherosclerosis is considered partly an inflam-
matory autoimmune disease, which might be triggered by binding
of autoreactive antibodies to the vascular endothelial surface [11].
Periodontitis was highly prevalent in our population, all of whom
had an initial indication for coronary angiography [19]. Periodontal
pathogens are likely to affect atherogenesis locally, while they have
frequently been found in atheromatous plaques [35]. The antibody
production towards periodontal pathogens has been shown to
auto-react with host antigens, and this molecular mimicry has been
proposed to indirectly mediate the atherogenic effects of peri-
odontitis [3,36,37]. The most studied periodontal pathogens in this
regard are A. actinomycetemcomitans and P. gingivalis, for which
several cross-reactive epitopes have been found [37,38]. Our ELISA
assays are based on whole cell antigens, therefore all potential
target epitopes, such as Hsp60, lipopolysaccharide and gingipain,
are accounted for.
One of the major issues in past research on periodontitis and
cardiovascular diseases has been the selection and heterogeneity of
periodontal diagnosis [7]. Even though clinical and radiographic
parameters have been widely used in studies on periodontitis and
cardiovascular disease, microbiological measures and respective
immune response have been proposed to better reflect the systemic
burden of periodontitis [39]. This approach is in line with a sys-
tematic review and meta-analysis, which showed that systemic
bacterial exposures are more pertinent in evaluation of athero-
sclerotic risk [40]. Moreover, our research group has previously
reported a positive association between periodontitis-related
serum antibodies and coronary outcomes in diverse populations
[28,41e43]. The present study complements the hypothesis pre-
sented by Beck and coworkers, as serum antibodies to periodontal
pathogens were stronger determinants for ACS than either peri-
odontal diagnosis, or subgingival bacterial counts.
While several infectious agents have been linked to athero-
genesis, it seems reasonable to simultaneously observe several
Fig. 1. Subgingival bacterial burden (x 105 bacteria) for seven periodontal pathogens
and immunological response (absorbance units) across groups of periodontal diagnosis
(mean, 95% CI).
Species-associated variables are summed and standardized. Diagnoses: healthy
(n ¼ 46), gingivitis (n ¼ 65), history of periodontitis (n ¼ 92), active periodontitis
(n ¼ 269), edentulous (n ¼ 33). * Levels differ from H; # levels differ from AP (Mann-
Whitney U, p < 0.05).
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“infectious burden”was first introduced by Zhu et al., who reported
on an aggregated risk for CAD when the patients had simultaneous
immune response to cytomegalovirus, Chlamydia pneumoniae,
hepatitis A virus and herpes simplex virus [16]. Oral infectious
burden and its immunologic response playing a part in the pro-
gression of CAD is widely accepted by the research community,
although research is relatively scarce to date [44]. Beck et al.
explored serum IgG levels specific for 17 periodontal micro-
organisms in N ¼ 4585 adults and concluded that systemic expo-
sure to oral organisms associates with subclinical atherosclerosis,
and this association was intensified when several bacteria were
grouped together [45]. In a much similar trend, Lund Håheim et al.
showed that IgG antibodies to four common periodontal pathogens
associates with self-reported myocardial infarction in multi-
adjusted analyses, but mainly when species were combined as in
the “infectious burden” concept [46].
Many previous seroepidemiologic studies on periodontitis and
CVD have been focused on IgG-antibodies whereas little is known
about IgA response, which might better reflect the recent bacterial
exposure due to shorter half-life time of this antibody. We have
previously reported that A. actinomycetemcomitans- and
P. gingivalis -specific serum IgA associates with myocardial infarc-
tion [41,43]. In a recent study by Boillot et al., systemic IgA levels to
four periodontal pathogens showed no association with major
cardiac events in a 1 year follow up of patients with prior
myocardial infarction [47]. An inconclusive association has been
reported for plasma IgG/IgA levels against four major periodontal
pathogens and the extent of coronary atherosclerosis, coronary
plaque vulnerability and coronary remodeling, although the sum of
IgA levels had an inverse association with positive lesion remod-
eling [48]. Recently, Palm et al. showed that
A. actinomycetemcomitans specific IgA levels associated with
ischemic stroke, but testing the “infectious burden” hypothesis led
to lost significance in the fully adjusted models [18]. The fact that
IgA burden for seven periodontal pathogens associated with ACS in
this study supports a positive dose-response relationship and
warrants further research. Our study is distinguished by a broader
view on periodontal microbes, as past investigations on immuno-
logic burden are mostly focused on A. actinomycetemcomitans and
P. gingivalis [10]. Taken together, a total infectious and immunologic
burden seems to be a promising approach for evaluating cardio-
vascular risk, but several questions remain in the appropriate se-
lection of antigens and methodology.
Our study setup stands out with simultaneous access to clinical
and radiographic oral data, microbiological analyses on subgingival
plaque, serological data on antibodies and precise angiographically
verified coronary outcomes. In the statistical analyses, we have
controlled for major cardiovascular confounders. The role of socio-
economic status as confounding factor is diminished, while all
Finnish adults have the same prerequisites and access to adequate
treatment. Autoantibody levels might be affected by sex hormones
andmenopause. This factor could not be controlled for in this study,
as our female population was mainly post-menopausal. Our com-
plementary analyses split by gender, suggested that the association
between immunologic burden and ACSmight be more apparent for
women, a factor that we suggest should be taken into account in
future studies.
Our study is cross sectional; hence, no conclusions of causality
can be made. The definitions for periodontal diagnosis are pub-
lished earlier [23]. But might differ from similar studies. Our study
population is limited to those with a simultaneous indication for
coronary angiography and capability to participate in thorough
examinations. Therefore, selection- and Neyman's bias is evident
and our cohort may not represent the general population, and our
Table 3
Subgingival burden, serum antibodies, and cardiovascular diagnosis.
Subgingival burden No CAD (n ¼ 138) Stable CAD (n ¼ 168) ACS (n ¼ 152)
Median (IQR) p-valuea
A. actinomycetemcomitans 0.49 (1.03) ¡0.30 (1.18) 0.034 0.49 (0.78) 0.980
P. gingivalis 0.48 (0.47) 0.47 (0.60) 0.675 0.48 (0.43) 0.795
P. endodontalis 0.44 (0.53) 0.43 (0.54) 0.595 0.46 (0.50) 0.398
P. intermedia 0.34 (0.80) 0.36 (0.88) 0.340 0.38 (0.90) 0.744
T. forsythia 0.39 (0.83) 0.35 (1.25) 0.237 0.47 (1.29) 0.793
C. rectus 0.38 (1.00) 0.35 (0.91) 0.622 0.45 (1.01) 0.737
F. nucleatum 0.35 (1.18) 0.33 (1.06) 0.816 0.44 (1.04) 0.528
Subgingival burden 0.31 (1.28) 0.26 (1.28) 0.375 0.47 (1.36) 0.713
IgA
A. actinomycetemcomitans 0.40 (1.01) 0.34 (1.13) 0.445 ¡0.18 (1.13) 0.002
P. gingivalis 0.58 (1.24) 0.45 (1.44) 0.363 0.42 (1.47) 0.070
P. endodontalis 0.47 (1.05) 0.39 (1.17) 0.216 0.33 (1.05) 0.096
P. intermedia 0.29 (1.03) 0.23 (1.19) 0.126 0.19 (1.02) 0.153
T. forsythia 0.35 (0.93) 0.15 (0.90) 0.061 0.29 (0.83) 0.079
C. rectus 0.32 (1.19) ¡0.08 (1.20) 0.009 ¡0.19 (1.16) 0.050
F. nucleatum 0.44 (0.99) 0.30 (0.81) 0.240 ¡0.24 (0.82) 0.009
IgA burden 0.41 (1.27) 0.24 (1.19) 0.164 ¡0.05 (1.19) 0.016
IgG
A. actinomycetemcomitans 0.41 (1.02) 0.24 (1.26) 0.200 ¡0.17 (1.34) 0.043
P. gingivalis 0.44 (1.59) 0.31 (1.79) 0.345 0.23 (1.63) 0.168
P. endodontalis 0.39 (1.61) 0.11 (1.72) 0.224 0.32 (1.36) 0.659
P. intermedia 0.26 (0.93) 0.20 (0.82) 0.885 0.17 (1.05) 0.191
T. forsythia 0.46 (0.97) 0.26 (1.07) 0.129 0.36 (1.18) 0.182
C. rectus 0.28 (1.19) 0.02 (1.45) 0.061 0.14 (1.19) 0.248
F. nucleatum 0.26 (1.15) 0.18 (1.14) 0.510 0.34 (1.17) 0.501
IgG burden 0.37 (1.78) 0.11 (1.71) 0.194 0.04 (1.43) 0.110
Levels of subgingival bacteria, serum antibodies (absorbance units) and their summed values were standardized with Z-score prior to analyses.
CAD, coronary artery disease; ACS, acute coronary syndrome; Ig, immunoglobulin.
a Mann-Whitney U test with "No CAD00 group used as reference; statistically significant results (p < 0.05) are bolded.
Table 4
Associations of IgA/IgG burden with cardiovascular diagnosis.
Antibody burden Stable CAD ACS
OR (95% CI) p-value OR (95% CI) p-value
IgA burden, Q24 Model 1 0.82 (0.46e1.46) 0.498 1.98 (1.13e3.47) 0.017
Model 2 0.75 (0.40e1.43) 0.383 1.84 (1.01e3.35) 0.045
IgG burden, Q24 Model 1 1.02 (0.58e1.80) 0.943 1.84 (1.04e3.23) 0.035
Model 2 0.91 (0.49e1.69) 0.760 1.87 (1.01e3.46) 0.045
Binomial logistic regression with "no CAD00 used as reference.
Levels of serum antibodies for A. actinomycetemcomitans, P. gingivalis, P. endodontalis, P. intermedia, T. forsythia, C. rectus and F. nucleatum (absorbance units) were standardized
with Z-score prior to summing into burden variables. Quartiles 2e4were compared to lowest quartile. Model 1 adjusted with age, gender, smoking (never/ever), dyslipidemia,
hypertension, diabetes, body mass index and number of teeth present. Model 2 additionally adjusted with subgingival burden and periodontal diagnosis (four groups).
Statistically significant results (p < 0.05) are bolded.
CAD, coronary artery disease; ACS, acute coronary syndrome; Ig, immunoglobulin.
J.M. Liljestrand et al. / Atherosclerosis 268 (2018) 177e184182study population included several older adults. It has been previ-
ously noted that age is a significant effect modifier for associations
between periodontitis and CVD [7], and that subgingival bacterial
species elicit a stronger systemic immune response in younger in-
dividuals [32,49,50], which might explain the modest associations
observed in this study. Our method for assessing immunologic
burden is somewhat crude and should therefore be interpreted
with caution. Antibodies to periodontal pathogens elicit a “friend or
foe” problem, as a normal immunologic response is essential for
both progression and restriction of periodontal disease. In addition,
a strong antibody response to periodontal pathogens might reflect
the immune responsiveness of the host, which is considered a
feature of CAD patients [11]. Therefore, the observed association
might be dependent on host characteristics: patients who are
susceptible to both periodontitis and CVD.
To conclude, we showed that periodontitis associates with
elevated levels of serum IgA/IgG antibodies for
A. actinomycetemcomitans, P. gingivalis, P. endodontalis, P. intermedia,
T. forsythia, C. rectus and F. nucleatum. Patient with activeperiodontitis had simultaneously elevated subgingival microbial
levels. Elevated serum antibody levels to these species were asso-
ciated with ACS. The relationship between periodontitis and car-
diovascular diseases might be partly mediated by the immunologic
responses to periodontal pathogens. A combined antibody burden
is a justified approach for evaluating this link, considering that
periodontitis is a multifactorial infectious disease with several
putative pathogens.
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